Skip to main content
Log in

Implications of a New Radiological Approach for the Assessment of Paget Disease

  • Original Research
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Abstract

In the present study, we quantified the proportion of skeletal involvement of Paget disease of bone (PDB) not captured by an abdominal X-ray. We also analyzed extension and severity over time and tested the hypothesis that X-rays from selected areas could replace bone scans for mapping PBD. We examined whole skeletal 99mTC-MDP bone scans from 208 consecutive untreated patients. Pagetic bones included in an abdominal X-ray were delimited; disease extension and activity were calculated using Coutris’s index as well as Renier’s index and serum alkaline phosphatase (AP) values, respectively. The study period (1965–2007) was divided into quartiles according to the date of the diagnosis. The percentage of patients with PDB captured by an abdominal X-ray was 79 % (95 % CI 74–85 %). In the last quartile vs. the first quartile, PDB was diagnosed at a more advanced age (67 ± 11 vs. 57 ± 9 years, respectively), with a lower median extension (4 vs. 7) and similar median activity (32 vs. 35) but less activity through median AP values (183 vs. 485 UI/L). The skeletal locations to X-ray in order to capture up to 93 % of PDB extension were the abdomen, skull with facial bones, and both tibias. In conclusion, one-fifth of patients are underdiagnosed when assessing prevalence of PDB by an X-ray of the abdomen, and there is a secular trend to presentation in older patients with a decreasing extension of the disease. A set of X-rays that includes abdomen, skull with facial bones, and both tibias provides a reliable alternative to bone scans.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Guañabens N, Garrido J, Gobbo M et al (2008) Prevalence of Paget’s disease of bone in Spain. Bone 43:1006–1009

    Article  PubMed  Google Scholar 

  2. Gennari L, Di Stefano M, Merlotti D et al (2005) Prevalence of Paget’s disease of bone in Italy. J Bone Miner Res 20:1845–1850

    Article  PubMed  Google Scholar 

  3. Barker DJ, Clough PW, Guyer PB, Gardner MJ (1977) Paget’s disease of bone in 14 British towns. Br Med J 1:1181–1183

    Article  PubMed  CAS  Google Scholar 

  4. Cooper C, Schafheutle K, Dennison E, Kellingray S, Guyer P, Barker D (1999) The epidemiology of Paget’s disease in Britain: is the prevalence decreasing? J Bone Miner Res 14:192–197

    Article  PubMed  CAS  Google Scholar 

  5. Altman RD, Bloch DA, Hochberg MC, Murphy WA (2000) Prevalence of pelvic Paget’s disease of bone in the united states. J Bone Miner Res 15:461–465

    Article  PubMed  CAS  Google Scholar 

  6. Doyle T, Gunn J, Anderson G, Gill M, Cundy T (2002) Paget’s disease in New Zealand: evidence for declining prevalence. Bone 31:616–619

    Article  PubMed  CAS  Google Scholar 

  7. Guyer PB (1981) Paget’s disease of bone: the anatomical distribution. Metab Bone Dis Relat Res 3:239–241

    Article  PubMed  CAS  Google Scholar 

  8. Kanis JA (1998) Radiological features. In: Kanis JA (ed) Pathophysiology and treatment of Paget’s disease of bone, 2nd edn. Martin Dunitz, London, pp 41–88

    Google Scholar 

  9. Cundy T, Bolland M (2008) Paget disease of bone. Trends Endocrinol Metab 19:246–253

    Article  PubMed  CAS  Google Scholar 

  10. Tiegs RD, Lohse CM, Wollan PC, Melton LJ (2000) Long-term trends in the incidence of Paget’s disease of bone. Bone 27:423–427

    Article  PubMed  CAS  Google Scholar 

  11. Poor G, Donath J, Fornet B, Cooper C (2006) Epidemiology of Paget’s disease in europe: the prevalence is decreasing. J Bone Miner Res 21:1545–1549

    Article  PubMed  Google Scholar 

  12. Morales-Piga AA, Bachiller-Corral FJ, Abraira V, Beltran J, Rapado A (2002) Is clinical expressiveness of Paget’s disease of bone decreasing? Bone 30:399–403

    Article  PubMed  CAS  Google Scholar 

  13. Delmas PD, Meunier PJ (1997) The management of Paget’s disease of bone. N Engl J Med 336:558–566

    Article  PubMed  CAS  Google Scholar 

  14. Selby PL, Davie MW, Ralston SH, Stone MD (2002) Guidelines on the management of Paget’s disease of bone. Bone 31:366–373

    Article  PubMed  CAS  Google Scholar 

  15. International Commission on Radiological Protection (1998) Radiation dose to patients from radiopharmaceuticals (addendum to ICRP publication 53). ICRP Publication 80. ICRP, Ottawa

  16. Tapiovaara M, Lakkisto M, Servomaa A (1997) Pcxmc: a PC-based Monte Carlo program for calculating patient doses in medical X-ray examinations. Finnish Centre for Radiation and Nuclear Safety, Helsinki

    Google Scholar 

  17. Needham G, Grimshaw J (2008) Radiation protection 118. Guidelines for healthcare professionals who prescribe imaging. Investigations involving ionising radiation. European Commission

  18. del Pino-Montes J, de Yébenes García, Prous MJ, Torrijos Eslava A et al (2009) Características de la enfermedad ósea de paget en españa. Datos del registro nacional de paget. Reumatol Clin 5:109–114

    Article  PubMed  Google Scholar 

  19. Coutris G, Cayla J, Rondier J, Talbot JN, Bonvarlet JP, Milhaud G (1975) Analise des perturbations des voies principales du metabolisme calcique dans la maladie de Paget. Effets de l’administration de calcitonine. Rev Rhum Mal Osteoartic 42:759–767

    PubMed  CAS  Google Scholar 

  20. Renier JC, Bontoux-Carre E, Seret P, Villayleck S (1984) Comment evaluer, en practique, l’activité de la maladie de Paget et quels malades trater? Rev Rhum Mal Osteoartic 51:463–468

    Google Scholar 

  21. Cuzick J (1985) A Wilcoxon-type test for trend. Stat Med 4:87–90

    Article  PubMed  CAS  Google Scholar 

  22. Efron B, Tibshirani R (1998) An introduction to the bootstrap. Chapman & Hall, New York

    Google Scholar 

  23. Smith SE, Murphey MD, Motamedi K, Mulligan ME, Resnik CS, Gannon F (2002) Radiologic spectrum of Paget disease of bone and its complications with pathologic correlation. Radiographics 22:1191–1216

    PubMed  Google Scholar 

  24. Meunier PJ, Salson C, Mathieu L et al (1987) Skeletal distribution and biochemical parameters of Paget’s disease. Clin Orthop Relat Res 217:37–44

    PubMed  Google Scholar 

  25. Wellman HN, Schauwecker D, Robb JA, Khairi MR, Johnston CC (1977) Skeletal scintimaging and radiography in the diagnosis and management of Paget’s disease. Clin Orthop Relat Res 127:55–62

    PubMed  Google Scholar 

  26. Fogelman I, Carr D (1980) A comparison of bone scanning and radiology in the assessment of patients with symptomatic Paget’s disease. Eur J Nucl Med 5:417–421

    PubMed  CAS  Google Scholar 

  27. Lavender JP, Evans IM, Arnot R et al (1977) A comparison of radiography and radioisotope scanning in the detection of Paget’s disease and in the assessment of response to human calcitonin. Br J Radiol 50:243–250

    Article  PubMed  CAS  Google Scholar 

  28. Vellenga CJ, Pauwels EK, Bijvoet OL, Frijlink WB, Mulder JD, Hermans J (1984) Untreated Paget disease of bone studied by scintigraphy. Radiology 153:799–805

    PubMed  CAS  Google Scholar 

  29. Cundy HR, Gamble G, Wattie D, Rutland M, Cundy T (2004) Paget’s disease of bone in New Zealand: continued decline in disease severity. Calcif Tissue Int 75:358–364

    Article  PubMed  CAS  Google Scholar 

  30. Peris P, Alvarez L, Vidal S et al (2006) Biochemical response to bisphosphonate therapy in pagetic patients with skull involvement. Calcif Tissue Int 79:22–26

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This work was funded by a Grant from Gebro Farmacéutica. We are most grateful to the Spanish Society of Rheumatology and the Spanish Society of Bone and Mineral Metabolism for their support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Núria Guañabens.

Additional information

The study was conducted on behalf of the Paget Study Group.

Investigators for the Paget Study Group are listed in the Appendix.

The authors have stated that they have no conflict of interest.

Appendix: PAGET Study Group

Appendix: PAGET Study Group

Investigators for the above study was conducted on behalf of the Paget Study Group: Antonio Torrijos Eslava, Hospital Universitario La Paz, Madrid; Javier Aguilar del Rey, Hospital Clínico Virgen de la Victoria, Málaga; Javier Bachiller Corral, Hospital Ramon y Cajal, Madrid; Javier Del Pino Montes and Judit Garcïa, Hospital Universitario De Salamanca, Salamanca; Jesús Beltrán Audera, Hospital Universitario Miguel Servet, Zaragoza; Jesús Tornero, Hospital Universitario de Guadalajara, Guadalajara; Jorge Malouf Sierra, Hospital Sant Pau y Santa Creu, Barcelona; José Antonio Piqueras, Hospital Universitario de Guadalajara, Guadalajara; José Manuel Gorordo Olaizola, Hospital De Basurto, Vizcaya; José Miguel Ruiz Martín, Hospital de Viladecans, Barcelona; José Santos Rey Rey, Hospital Virgen de la Salud, Toledo; Juan Antonio Castellano Cuesta, Hospital Arnau de Vilanova, Valencia; Lucia Pantoja Zarza, Hospital del Bierzo, León; M. Angeles Martinez Ferrer, Hospital Clinic i Provincial, Barcelona; M. Asunción Salmoral Chamizo, Hospital Reina Sofía, Córdoba; Manuel Rodríguez Pérez, Hospital Universitario Carlos Haya, Málaga; Nicolás Chozas Candanedo, Hospital Universitario Puerta del Mar, Cádiz; Rosa Roselló Pardo, Hospital San Jorge, Huesca.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Guañabens, N., Rotés, D., Holgado, S. et al. Implications of a New Radiological Approach for the Assessment of Paget Disease. Calcif Tissue Int 91, 409–415 (2012). https://doi.org/10.1007/s00223-012-9652-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00223-012-9652-z

Keywords

Navigation